A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)  by Suzuki, Kenji et al.
ORIGINAL ARTICLE
A Prospective Radiological Study of Thin-Section
Computed Tomography to Predict Pathological
Noninvasiveness in Peripheral Clinical IA Lung Cancer
(Japan Clinical Oncology Group 0201)
Kenji Suzuki, MD, Teruaki Koike, MD, Takashi Asakawa, BSc, Masahiko Kusumoto, MD,
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Masahiro Tsuboi, MD, Taro Shibata, MSc, Haruhiko Fukuda, MD,
and Harubumi Kato, MD, On behalf of the Japan Lung Cancer Surgical Study Group (JCOG LCSSG)
Purpose: Pathological noninvasiveness needs to be precisely pre-
dicted in preoperative radiological examinations of patients with
early lung cancer for the application of limited surgery.
Patients and Methods: Patients with clinical T1N0M0 peripheral
lung cancer were recruited. Radiological findings of the main tumor
were evaluated as to ground-glass opacity with thin-section com-
puted tomography. The primary end point was specificity, i.e., the
proportion of patients with radiologically diagnosed invasive lung
cancer to patients with pathologically diagnosed invasive lung
cancer. The precision-based planned sample size was 450. We
expected that the lower limit of the 95% confidence interval (CI) for
specificity should be satisfied in 97% of patients.
Results: We enrolled 811 patients from 31 institutions between
December 2002 and May 2004. The primary end point was evalu-
ated in 545 patients. The specificity and sensitivity for the diagnosis
of pathologically diagnosed invasive cancer were 96.4% (161/167,
95% CI: 92.3–98.7%) and 30.4% (115/378, 95% CI: 25.8–35.3%),
respectively, i.e., a negative result. Nevertheless, the specificity for
lung adenocarcinoma 2.0 cm with 0.25 consolidation to the
maximum tumor diameter was 98.7% (95% CI: 93.2–100.0%), and
this criterion could be used to radiologically define early adenocar-
cinoma of the lung.
Conclusions: Although our predetermined criterion for specificity
was not statistically confirmed, radiological diagnosis of noninva-
sive lung cancer with a thin-section computed tomography scan
corresponded well with pathological invasiveness. Radiological
noninvasive peripheral lung adenocarcinoma could be defined as an
adenocarcinoma 2.0 cm with 0.25 consolidation.
Key Words: Ground-glass opacity, Bronchioloalveolar carcinoma,
Thin-section, Computed tomography, Limited resection.
(J Thorac Oncol. 2011;6: 751–756)
Lung cancer is the leading cause of cancer death world-wide.1 Occult lymph node metastasis in hilum and medi-
astinum are found in approximately 15 to 20% in the litera-
ture2,3; however, a conventional preoperative workup cannot
detect these metastases. Thus, a major lung resection with
lymphadenectomy is recommended even for small-sized lung
cancer.
There are two indications for the use of limited surgical
resection. Some authors insist that only the size of the main
tumor is an indication for limited surgical resection.4–6 This
strategy is supported by segmentectomy as the limited sur-
gery and an intraoperative evaluation of the hilar lymph node.
If there is lymph node involvement, then the surgery is
converted from segmentectomy to major lung resection.
Thus, diagnosis from intraoperative frozen sections of several
lymph nodes is mandatory for this strategy, and a wide wedge
resection, another limited surgical resection technique, is not
suitable because it is impossible to evaluate the status of the
hilar nodes using this approach. Conversely, a wide wedge
resection can be used as a limited surgical resection for
peripheral lung cancer.7–9 This strategy should be adopted on
the supposition that the lung cancer has not metastasized to
the nodes. As the intraoperative nodal status cannot be esti-
mated using a wide wedge resection, a preoperative evalua-
tion of the primary tumor is vital. Preoperative predictors for
the lack of metastasis to the lymph node are necessary for this
strategy. The findings from thin-section computed tomogra-
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phy (CT) are reported to be the best predictors for the
invasiveness and nodal status of lung cancers.10–17 It has been
proposed that lung cancer with a consolidation less than 50%
of the maximum tumor diameter could be one of the most
promising definitions to predict “early” lung cancer; how-
ever, this definition was derived from retrospective studies,
and it should be confirmed in a prospective study.
Therefore, we performed a multiinstitutional prospec-
tive study for the radiological diagnosis of early lung cancer
(Japan Clinical Oncology Group [JCOG] 0201) to assess
these retrospective findings. If the validity of the criteria to
radiologically diagnose “early” lung cancer is confirmed by
this study, then a limited surgical resection could be used
instead of a major lung resection.
PATIENTS AND METHODS
Patient Eligibility Criteria
The eligibility criteria were as follows: (1) a suspected
or diagnosed lung cancer based on the findings from a plain
x-ray and/or CT scan; (2) clinical stage IA, i.e., T1N0M0, by
thoracic enhanced CT; (3) the center of the tumor was located
peripherally, i.e., the outer half of the lung field on CT; (4)
measurable at least in one dimension in thin section CT; (5)
age range from 20 to 75 years, (6) no prior thoracotomy; (7)
feasible for pulmonary lobectomy; and (8) obtained written
informed consent.
The exclusion criteria included (1) synchronous or
metachronous (within 5 years) malignancy other than carci-
noma in situ and (2) interstitial pneumonitis, lung fibrosis, or
severe pulmonary emphysema.
All patients underwent a preoperative CT scan, and
hilar or mediastinal nodes less than 1.0 cm in the shortest
diameter were regarded as clinical N0. Disease stages were
determined based on the tumor node metastasis classification
of the International Union Against Cancer, 6th edition.18 The
study protocol was approved by the JCOG Clinical Trial
Review Committee and by the institutional review board of
each participating center. The JCOG Data Center conducted
the central registration, data management, central monitoring,
and statistical analysis.
Radiological Evaluation of the Primary Tumor
A contrast-enhanced CT scan was performed to evalu-
ate the entire lung for preoperative staging. In addition, the
main tumor was evaluated preoperatively to estimate the
extent of ground-glass opacity (GGO) with thin-section he-
lical CT scan with 1 to 3 mm collimation. Images were
reconstructed with a field of view of 15 to 20 cm. The lung
was photographed with a window level of 500 to 700 H
and a window width of 1000 to 2000 H as a lung window
setting, and with a window level of 30 to 60 H and a window
width of 350 to 600 H as a mediastinal window setting. The
evaluated factors on the lung window were the maximum
diameters of the tumor and consolidation; the presence of a
pleural tail; air bronchogram; the homogeneity of consolida-
tion; and the sharpness of the tumor margin. The maximum
tumor diameter was also evaluated from the mediastinal
window. The consolidation component was defined as an area
of increased opacification that completely obscured the un-
derlying vascular markings. GGO was defined as an area of a
slight, homogenous increase in density that did not obscure
the underlying vascular markings.
Surgical Intervention
A preoperative needle biopsy or cytology was not
required. When the diagnosis of lung adenocarcinoma was
preoperatively made, a lobectomy and lymph node dissection
were recommended; otherwise, an intraoperative frozen sec-
tion diagnosis was performed, and if the tumor had histology
other than adenocarcinoma, the protocol treatment was ter-
minated, and the patients were excluded from the analysis. If
the tumor was intraoperatively diagnosed as an adenocarci-
noma, major lung resection and lymph node dissection were
recommended. For some adenocarcinomas with large GGO
areas, such as “pure GGO,” a limited surgical resection was
allowed, but this population was excluded from the primary
end point analysis.
Pathological Diagnosis
The resected specimen was sectioned at intervals of 5 to
10 mm throughout the whole lung. The main tumor was
sectioned into 2 to 4 mm slices, and the following patholog-
ical factors were evaluated by means of hematoxylin and
eosin staining, and elastic fiber staining: histological typing;
grade of differentiation; Noguchi’s classification19; the max-
imum diameter of the main tumor and central fibrosis; pleural
involvement; vascular invasion; lymphatic invasion; and in-
trapulmonary metastasis. Histological typing was determined
according to the classification system of the World Health
Organization.20
Study Design
Surgical resection was performed after the radiological
evaluation of the peripherally located adenocarcinoma. The
mode of surgery was basically a pulmonary lobectomy and
lymph node dissection, and the postoperative pathological
diagnosis was compared with the preoperative radiological
diagnosis of early lung cancer. If the postoperative patholog-
ical diagnosis of “noninvasive adenocarcinoma” of the lung
was predicted by the preoperative radiological diagnosis, a
limited surgical resection or other nonsurgical local therapy
was indicated.
Definition of Radiological Noninvasive and
Invasive Lung Cancer
On the basis of retrospective findings,10–15 radiological
noninvasive lung cancer was tentatively defined as a tumor
with a maximum diameter of consolidation of the maximum
tumor diameter (consolidation/tumor ratio, C/T ratio) less
than 0.5, indicating a tumor with a wide GGO area (Figure 1).
Additionally, we adopted other criteria for radiological non-
invasive lung cancer. One was the tumor shadow disappear-
ance rate (TDR),17 and the other was the visual estimation
(VE) of the consolidation component.11 TDR was evaluated
from the maximum tumor diameter on the lung and medias-
tinum windows. TDR was calculated using the following
formula: TDR  tumor size on mediastinal window/tumor
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size on lung window. For VE, the consolidation component
was defined as the proportion of the area of consolidation to
that of the tumor visually estimated without measuring the
diameter; a value less than 0.5 was diagnosed as noninvasive
cancer. We compared the sensitivity and specificity of these
three methods of radiological evaluation.
Definition of Pathological Noninvasive and
Invasive Lung Cancer
The provisional pathological definition of noninvasive
lung cancer was defined as a lung adenocarcinoma without
nodal involvement, vascular invasion, or lymphatic invasion.
End Point and Planned Sample Size
The primary end point was the specificity based on the
radiological diagnosis using the C/T ratio. The relationship
between the radiological and pathological diagnoses is pre-
sented in Table 1. If limited surgical resection was performed
on a patient with radiological noninvasive but pathological
invasive cancer, the treatment was considered as “undertreat-
ment” (group C, Table 1). Conversely, if major surgical
resection was performed on a patient with radiological inva-
sive but pathological noninvasive cancer, the treatment was
defined as “overtreatment” (group B), and a limited surgical
resection may be indicated. Patients with radiological and
pathological noninvasive lung cancer belonged to group A;
group D included patients with radiological and pathological
invasive lung cancer. Considering that local recurrence of lung
cancer results in a dismal prognosis, undertreatment should be
avoided at any cost. Therefore, the number of patients belonging
to “C” of Table 1 should be minimized, and the primary end
point of specificity was defined as the proportion of patients with
radiologically diagnosed invasive lung cancer in patients with
pathologically diagnosed invasive lung cancer, i.e., D/(C  D).
Conversely, patients with radiological invasive but pathological
noninvasive lung cancer, who belong to category “B,” may
undergo overtreatment. The number of patients in the “B”
category should be minimized, and sensitivity was selected as a
secondary end point. Sensitivity was defined as the proportion of
patients with radiologically diagnosed noninvasive cancer in
patients with pathologically diagnosed noninvasive cancer, i.e.,
A/(A  B).
The primary end point was evaluated for the patients
who were resected with a lobectomy and lymph node dissec-
tion, diagnosed with adenocarcinoma, and who were regarded
as eligible in the radiological central review. We expected
that the lower limit for the 95% confidence interval (CI) of
specificity was satisfied in 97% of patients for an estimated
sample size of 400 pathological invasive cancer cases. As-
suming the sensitivity is 50% and the 95% CI range is15%,
the estimated sample size for pathological noninvasive cancer
was 50 cases. The precision-based planned sample size was
450, i.e., 400 cases for pathological invasive cancers and
50 cases for pathological noninvasive cancers.
Central Review of Radiological Evaluation
To ensure the final diagnosis, radiological findings based
on thin-section CT were reviewed by six reviewers. This radio-
logical central review was indicated for patients who were
preoperatively or intraoperatively diagnosed with adenocarci-
noma. CT findings were evaluated coincidentally by the six
reviewers, and the final results were decided in consensus.
Exploratory Analysis
We conducted additional exploratory analyses for pa-
tients with an adenocarcinoma 2.0 cm in size and evaluated
the specificity and sensitivity. We also evaluated two other
cutoff values for the C/T ratio on lung window, 0.25 and 0.75,
to identify the optimal cutoff value to predict pathologically
noninvasive adenocarcinoma of the lung.
RESULTS
Patients’ Characteristics
Between December 2002 and May 2004, we enrolled
811 patients from 31 institutions. We expected that the
number of pathological noninvasive and invasive cancers was
50 and 400, respectively; however, we recruited patients with
FIGURE 1. Example of radiological noninvasive lung can-
cer. The maximum diameter of consolidation (B) is less than
the half of the maximum tumor diameter (A), which means
tumor with wide area of ground glass opacity.
TABLE 1. Relationship Between Radiological and
Pathological Features
Radiological Diagnosis
Pathological Diagnosis
Noninvasive Invasive
Noninvasivea A C—undertreated
Invasive B—overtreated D
a Radiological noninvasive lung cancer was tentatively defined as a tumor with a
maximum diameter of consolidation of the maximum tumor diameter 0.5 (see text).
Specificity  D/(C  D), sensitivity  A/(A  B), positive predictive value 
A/(A  C), and negative predictive value D/(B  D).
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more pathological noninvasive and less invasive cancer than
expected. Thus, we increased the total sample size to recruit
more than 400 patients with pathological invasive cancer.
Nevertheless, the primary end point proved to be lower than
expected before sufficient numbers of pathological invasive
cancer cases were recruited. Therefore, the accrual of patients
was terminated before the planned period. We recruited 357
men and 454 women (age range, 27–75 years; median, 61
years). Among them, 671 (82.7%) patients were diagnosed
with lung adenocarcinoma at the time of the surgical resec-
tion. The other cases included benign pathology or other type
of cancers, such as pulmonary metastasis of colorectal cancer.
Of the 671 patients with lung adenocarcinoma, 562 (83.8%)
underwent major lung resection, 103 (15.3%) underwent
limited resection, five (0.75%) underwent exploratory thora-
cotomy, and one underwent another procedure. Among the
562 patients, 17 (3.0%) patients were ineligible based on their
postoperative pathological findings (Figure 2). Thus, the
remaining 545 patients satisfied the inclusion criteria (de-
scribed in the Patients and Methods section) and were taken
into the primary analysis (Table 2).
Evaluation of the Primary End Point and
Comparison among the Three Methods of
Radiological Evaluation
The primary end point was evaluated among the 545
patients who met the inclusion criteria (Table 3). The speci-
ficity and sensitivity of the diagnosis for pathologically inva-
sive cancer based on the C/T ratio from the lung window was
96.4% (161/167, 95% CI: 92.3–98.7%) and 30.4% (115/378,
95% CI: 25.8–35.3%), respectively. As a result, the lower
95% CI limit for specificity did not exceed the prespecified
threshold of 97%. The specificity and sensitivity for the
diagnosis of pathologically invasive cancer based on the TDR
from the mediastinal window was 89.8% (150/167, 95% CI:
84.2–94.0%) and 44.4% (168/378, 95% CI: 39.4–49.6%),
respectively. The most favorable specificity was obtained by
the evaluation of the C/T ratio, and the lowest specificity was
observed by the TDR method.
Radiological-Pathological Association in Lung
Adenocarcinoma <2.0 cm in Size
Additional exploratory analysis was performed for lung
adenocarcinoma 2.0 cm in size in the maximum tumor
dimension to examine the appropriate tumor size for diagno-
sis of radiological early lung cancer. The specificity and
sensitivity for the diagnosis of pathological invasive cancer
based on the C/T ratio from the lung window was 97.5%
(95% CI: 91.2–99.7%) and 31.0% (65/210, 95% CI: 24.8–
37.7%), respectively. The point estimate of specificity was
FIGURE 2. Scheme for study population. Finally, 545 pa-
tients with adenocarcinoma were the population for the pri-
mary analysis.
TABLE 2. Characteristics of 545 Eligible Patients for the
Investigation of the Primary Endpoint
Characteristics Number of Patients
Clinical factors
Gender
Men 233
Women 312
Age range (median) 35–75 (62)
Maximum tumor dimension
1.0cm 30
1.0–2.0 270
2.0–3.0 243
3.0 2
Radiological factors
Cons/Tumor ratioa
Non-invasive ( 0.5) 137
The others ( 0.5) 381
TDRb
Non-invasive ( 0.5) 234
The others ( 0.5) 311
Visual estimation of consolidationc
Non-invasive ( 0.5) 200
The others ( 0.5) 345
Surgical factors
Type of surgery
Pneumonectomy 1
Lobectomy 544
Pathological factors
Final histological diagnosisd
Adenocarcinoma 529
Squamous cell carcinoma 7
Large cell carcinoma 4
Others 5
Lymph node metastasis
Positive 47
Negative 498
Vascular invasione
Positive 100
Negative 443
Lymphatic invasionf
Positive 113
Negative 428
a There were 27 cases of which tumors could not be evaluated the size of
consolidation on lung window because of their unclear margin.
b TDR was calculated with the following formula: TDR  tumor size on medias-
tinal window/tumor size on lung window.
c The size of consolidation component was evaluated with visual estimation.
d Patients with adenocarcinoma which was diagnosed at the time of surgery were
eligible and there were 16 patients with different final pathological diagnosis.
e There were one missing data and one unknown findings.
f There were one missing data and three unknown findings.
Cons, consolidation, TDR: tumor disappearance ratio.
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higher than observed in the primary analysis, but the lowest
limit of the 95% CI for specificity was still lower than 97%.
Evaluation of the Optimal Cutoff Value for the
C/T Ratio
Radiologically noninvasive lung cancer was primarily
defined in this study as a C/T ratio less than 0.5 on thin-
section CT; however, the specificity for this criterion was
lower than expected, so we examined two other cutoff values,
0.25 and 0.75, for the C/T ratio in patients with lung adeno-
carcinoma 2.0 cm in size. As a result, the 0.25 cutoff value
showed the highest specificity, although its sensitivity was
relatively low (Table 4).
DISCUSSION
This is the first multiinstitutional prospective study on
the definition of radiological early lung cancer. Several ra-
diological criteria for early lung cancer have been reported,
but these reports were based on retrospective and single
institute analysis.10–15 The majority of these reports sup-
ported the hypothesis that lung cancer with a consolidation
less than 0.5 of the maximum tumor diameter and a wide
GGO could be regarded as early lung cancer. If this hypoth-
esis was correct, then a limited surgical resection, instead of
lobectomy, should be sufficient to treat this population. Nev-
ertheless, before generalizing the strategy, we had to confirm
this hypothesis obtained from retrospective findings on a
multiinstitutional basis. On the basis of our results, although
the radiological findings of GGO and consolidation were well
correlated with the pathologically invasive nature of the
tumor, the radiological criteria for early lung cancer using the
50% cutoff value were not valid to predict pathological
noninvasiveness. Thus, based on this exploratory analysis,
lung carcinoma 2.0 cm in size and with a consolidation
25% of the maximum tumor diameter was considered to be
radiological early lung cancer. We have just started a clinical
trial to evaluate the validity of limited resection for lung
cancer based on these criteria.
There has not been a general consensus formed on the
optimal method to evaluate the extent of GGO. Three meth-
ods have been mainly reported: the C/T ratio from the lung
window; the TDR from the mediastinal window; and the VE
of the extent of GGO from the lung window. Each method
has been reported as an optimal method based on a single
institute retrospective analysis.10–15 This study is the first
prospective study to compare the three methods. The highest
specificity was obtained from the C/T ratio and was the
lowest for the TDR method. Conversely, the highest sensi-
tivity was found with the TDR method, and the lowest was
for the C/T ratio. Therefore, if the TDR method was used to
determine radiological early lung cancer, more invasive can-
cers would be misdiagnosed as radiologically noninvasive.
This situation should be avoided as much as possible because
an invasive cancer would be resected using a limited resec-
tion that is ill suited for such cancers. Conversely, the C/T
ratio provided clinically safe criteria to identify noninvasive
cancers. On the basis of the primary analyses, the C/T ratio
was the best criterion for the highest specificity. In this trial,
TABLE 3. Relationship Between Radiological and
Pathological Features in the 545 Eligible Cases
Radiology (Cutoff: 0.5)a
Pathological Diagnosisb
Noninvasive Invasive
Consolidation/tumor
ratio on lung window
Noninvasivea 115 6
Invasive 263 161
Sensitivity 30.4% (95% CI: 25.8–35.3)
Specificity 96.4% (95% CI: 92.3–98.7)
TDR
Noninvasivea 168 17
Invasive 210 150
Sensitivity 44.4% (95% CI: 39.4–49.6)
Specificity 89.8% (95% CI: 84.2–94.0)
Visual estimation of
consolidation
Noninvasivea 140 11
Invasive 238 156
Sensitivity 37.0% (95% CI: 32.2–42.1)
Specificity 93.4% (95% CI: 88.5–96.7)
a Radiological noninvasive lung cancer was tentatively defined as a tumor with a
maximum diameter of consolidation of the maximum tumor diameter 0.5, indicating
a tumor with a wide GGO area (see text).
b Pathological diagnosis was based on the criteria using nodal status, lymphatic
invasion, and vascular invasion.
TDR, tumor disappearance ratio; CI, confidence interval; GGO, ground-glass
opacity.
TABLE 4. Radiologic-Pathologic Correlation in Lung Cancer
2.0 cm or Less in Size (Cutoff: 0.25)
Radiology (Cutoff: 0.25)a
Pathological Diagnosisb
Noninvasive Invasive
Consolidation/tumor ratio
on lung window
Noninvasivea 34 1
Invasive 176 78
Sensitivity 16.2% (95% CI: 11.5–21.9)
Specificity 98.7% (95% CI: 93.2–100.0)
TDR
Noninvasivea 58 3
Invasive 152 76
Sensitivity 27.6% (95% CI: 21.7–34.2)
Specificity 96.2% (95% CI: 89.3–99.2)
Visual estimation of
consolidation
Noninvasivea 26 0
Invasive 184 79
Sensitivity 12.4% (95% CI: 8.3–17.6)
Specificity 100.0% (95% CI: 95.4–100.0)
a Radiological noninvasive lung cancer was tentatively defined as a tumor with a
maximum diameter of consolidation of the maximum tumor diameter 0.25, indicating
a tumor with a wide GGO area (see text).
b Pathological noninvasive is defined as adenocarcinoma with no nodal involve-
ment, lymphatic invasion, or vascular invasion.
TDR, tumor disappearance ratio; GGO, ground-glass opacity; CI, confidence
interval.
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mode of surgery is not controlled for GGO lesions. Such
GGO lesions were not included in the primary analysis
because of limited surgery which was indicated for these. If
these lesions were included for the analysis, sensitivity may
increase with a slight decrease of specificity. The point
estimate of specificity was much higher for lung cancer 2.0
cm in size. When the cutoff value was set as 0.25, the
specificity was the highest. In short, a pathological noninva-
sive cancer can be predicted by a C/T ratio with a cutoff value
of 0.25 and a specificity of 98.7% (95% CI: 93.2–100.0%) for
lung cancer 2.0 cm in size. Thus, we prefer to use the
criteria derived from the lung window to select candidates to
undergo a limited resection.
Major lung resection has been recommended as a stan-
dard procedure, even for small-sized lung cancer, because
lymph node metastasis can be found in approximately 15% of
lung cancers 2.0 cm size.2 Nevertheless, our radiological
criteria could be used to predict pathological noninvasive-
ness, and such patients would be candidates to undergo a
limited surgical resection. Limited pulmonary resection con-
sists of wide wedge resection or segmentectomy. As for
surgical invasiveness, a wedge resection can be performed
with a smaller skin incision, reduced blood loss, and a shorter
operation time. On the other hand, segmentectomy offers a
sufficient surgical margin. To select the optimal limited
resection, the key note is the status of lymph node metastasis.
A wide wedge resection should be indicated for lung cancer
without lymph node involvement.
In conclusion, although our predetermined criterion for
specificity was not statistically confirmed, the radiological
diagnosis of noninvasive lung cancer using a thin-section CT
scan correlated well with pathological invasiveness based on
the exploratory investigation. We are planning to perform a
study of the efficacy of limited surgical resection for lung
cancers selected by the criterion using a cutoff value of 0.25
and a maximum tumor diameter2.0 cm in size. We will use
a wide wedge resection as the limited surgical procedure
because these cases have a limited potential for nodal in-
volvement or lymphatic/vascular invasion. We are also plan-
ning to perform a phase III trial to compare pulmonary
lobectomy and segmentectomy for lung cancer 2.0 cm in
size, excluding patients with radiological noninvasive cancer.
If we obtain positive results in these future clinical trials, it
will present a good opportunity to change the standard treat-
ment for early-stage lung cancer.
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